退伍军人临床I期非小细胞肺癌手术治疗中的种族差异
本研究回顾性分析2006至2016年VHA系统内18800例临床I期NSCLC退伍军人,比较黑人与白人患者的手术治疗率、手术质量及肿瘤结局。结果显示两组根治性手术率相似(57.3% vs 58.1%,P=.42),黑人患者风险校正总生存更优(HR 0.802,95%CI 0.729-0.883,P<.001),提示VHA内黑人患者接受可比医疗且结局不劣于甚至优于白人患者。
要点
- VHA内临床I期NSCLC黑人退伍军人根治性手术率与白人相似(57.3% vs 58.1%,P=.42)。
- 黑人患者风险校正总生存更优(HR 0.802,95%CI 0.729-0.883,P<.001)。
- 两组淋巴结充分采样率接近但黑人略低(30.6% vs 33.3%;P=.050)。
核心结论
- 在VHA接受手术治疗的临床I期NSCLC退伍军人中,黑人患者接受与白人可比的医疗,结局相当甚至更优。
研究设计与样本
- 回顾性队列研究,纳入2006至2016年VHA系统内接受手术治疗的临床I期NSCLC退伍军人共18800例。
- 最终手术队列9842例,其中白人8356例(84.9%),黑人1486例(15.1%)。
主要发现
- 黑人退伍军人根治性手术率为57.3%,白人为58.1%(P=.42)。
- 黑人患者更年轻且更可能吸烟,但两组合并症相似。
- 黑人患者淋巴结充分采样率略低(30.6% vs 33.3%;P=.050)。
- 解剖性肺叶切除率(71.9% vs 69.4%;P=.189)和切缘阳性率(3.2% vs 3.1%;P=.955)两组相似。
- 黑人患者风险校正总生存更优(HR 0.802;95%CI 0.729-0.883;P<.001),30天再入院、30天死亡率及无病生存无差异。
临床怎么用
- VHA内临床I期NSCLC黑人退伍军人接受手术治疗的短期与长期结局与白人相当或更优。
- 应继续监测淋巴结采样等手术质量指标在种族间的差异。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Prior studies in the civilian population have reported racial disparities in lung cancer outcomes following surgical treatment, including inferior quality of care and worse survival. It is unclear if racial disparities exist in the Veterans Health Administration (VHA), the largest integrated health care system in the United States. RESEARCH QUESTION: Do racial disparities affect early-stage non-small cell lung cancer (NSCLC) outcomes following surgical treatment within the VHA? STUDY DESIGN AND METHODS: This retrospective cohort study was conducted in veterans with clinical stage I NSCLC undergoing surgical treatment in the VHA system. Demographic characteristics, access to care, surgical quality measures, and short- and long-term oncologic outcomes between White and Black veterans were evaluated. RESULTS: From 2006 to 2016, a total of 18,800 veterans with clinical stage I NSCLC were included. The rates of definitive surgical treatment were similar between Black (57.3%) and White (58.1%) veterans (P = .42). The final study cohort included 9,842 patients receiving surgical treatment, of whom 8,356 (84.9%) were White and 1,486 (15.1%) were Black. Black patients were younger and more likely to smoke, although comorbidities were similar between the two groups. Black patients were somewhat less likely to receive adequate lymph node sampling (30.6% vs 33.3%; P = .050); however, other access-to-care metrics and surgical quality measures, including rates of anatomic lobectomy (71.9% vs 69.4%; P = .189) and positive margins (3.2% vs 3.1%; P = .955), were similar between the two groups. Although Black veterans were less likely to experience major postoperative complications, there was no difference in 30-day readmission, 30-day mortality, or disease-free survival between the two groups. Black patients had significantly better risk-adjusted overall survival (hazard ratio, 0.802; 95% CI, 0.729-0.883; P < .001). INTERPRETATION: Among veterans with NSCLC undergoing surgical treatment through the VHA, Black patients received comparable care with equivalent if not superior outcomes compared with White patients.
引用
- Heiden BT, Eaton DB, Chang SH, et al. Racial Disparities in the Surgical Treatment of Clinical Stage I Non-Small Cell Lung Cancer Among Veterans. Chest. 2022. PMID: 35405111. doi:10.1016/j.chest.2022.03.045
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。